Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Sep-24 4:04 PM View:  | Spyre Therapeutics, Inc. (SYRE) | 03-Sep-24 | Private Sale | 18,531 | $28.17 | $522,074.00 | (14%) 134.95K to 116.42K | |
| 22-Dec-23 6:00 PM View: | Spyre Therapeutics, Inc. (SYRE) | 22-Dec-23 | Grant | 134,953 | -- | -- | 100% 0 to 134.95K | |
| 08-Mar-23 4:29 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 06-Mar-23 | Sale (Planned) | 291 | $15.26 | $4,441.65 | (< 1%) 59.41K to 59.12K | |
| 06-Mar-23 6:58 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 02-Mar-23 | Grant | 21,000 | -- | -- | 55% 38.41K to 59.41K | |
| 02-Mar-23 7:05 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 02-Mar-23 | Sale (Planned) | 1,434 | $15.83 | $22,696.10 | (4%) 39.84K to 38.41K | |
| 02-Mar-23 7:05 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 28-Feb-23 | Market Sale (Planned) | 416 | $16.17 | $6,725.18 | (1%) 40.26K to 39.84K | (17%) |
| 20-Sep-22 4:37 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 16-Sep-22 | Option Exercise | 5,000 | $1.68 | $8,403.00 | 14% 35.26K to 40.26K | |
| 07-Mar-22 8:49 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 07-Mar-22 | Sale (Planned) | 10 | $16.44 | $164.45 | (< 1%) 35.27K to 35.26K | |
| 07-Mar-22 8:49 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Mar-22 | Sale (Planned) | 293 | $16.86 | $4,939.72 | (< 1%) 35.56K to 35.27K | |
| 07-Mar-22 8:49 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 03-Mar-22 | Grant | 13,300 | -- | -- | 60% 22.26K to 35.56K | |
| 03-Mar-22 10:00 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Mar-22 | Market Sale (Planned) | 420 | $17.75 | $7,456.13 | (2%) 22.68K to 22.26K | (6%) |
| 28-Dec-21 5:00 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 27-Dec-21 | Market Sale (Planned) | 12,560 | $20.07 | $252,140.00 | (36%) 35.24K to 22.68K | (< 1%) |